E
Elizabeth M. Morse
Researcher at Yale University
Publications - 11
Citations - 4184
Elizabeth M. Morse is an academic researcher from Yale University. The author has contributed to research in topics: Integrin & Integrin, beta 6. The author has an hindex of 10, co-authored 10 publications receiving 3583 citations. Previous affiliations of Elizabeth M. Morse include Massachusetts Institute of Technology & Harvard University.
Papers
More filters
Journal ArticleDOI
Selective inhibition of BET bromodomains.
Panagis Filippakopoulos,Jun Qi,Sarah Picaud,Yao Shen,William B. Smith,Oleg Fedorov,Elizabeth M. Morse,T. Keates,Tyler T. Hickman,I. Felletar,Martin Philpott,Shonagh Munro,Michael R. McKeown,Yuchuan Wang,Amanda L. Christie,Nathan West,Michael J. Cameron,Brian E. Schwartz,Tom D. Heightman,Nicholas B. La Thangue,Christopher A. French,Olaf Wiest,Andrew L. Kung,Stefan Knapp,Stefan Knapp,James E. Bradner +25 more
TL;DR: A cell-permeable small molecule (JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains is reported, establishing proof-of-concept for targeting protein–protein interactions of epigenetic ‘readers’, and providing a versatile chemical scaffold for the development of chemical probes more broadly throughout the b romodomain family.
Journal ArticleDOI
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
James E. Bradner,Raymond H. Mak,Shyam K. Tanguturi,Ralph Mazitschek,Stephen J. Haggarty,Kenneth N. Ross,Cindy Y. Chang,Jocelyn Bosco,Nathan West,Nathan West,Elizabeth M. Morse,Elizabeth M. Morse,Katherine Lin,John Paul Shen,Nicholas Kwiatkowski,Nele Gheldof,Job Dekker,Daniel J. DeAngelo,Steven A. Carr,Stuart L. Schreiber,Stuart L. Schreiber,Stuart L. Schreiber,Todd R. Golub,Todd R. Golub,Todd R. Golub,Benjamin L. Ebert,Benjamin L. Ebert +26 more
TL;DR: A unique bead-based strategy is developed for the identification of inducers of fetal hemoglobin transcripts in primary human erythroid cells and the potential of isoform-selective inhibitors of HDAC1 and HDAC2 for the treatment of sickle cell disease is suggested.
Journal ArticleDOI
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.
Wangko Lundström,Steven L. Highfill,Scott T. R. Walsh,Stephanie Beq,Elizabeth M. Morse,Ingrid Kockum,Lars Alfredsson,Tomas Olsson,Jan Hillert,Crystal L. Mackall +9 more
TL;DR: It is demonstrated that sIL7Rα potentiates IL-7 bioactivity and provides a basis to explain the increased risk of autoimmunity observed in individuals with genotype-induced elevations of sIL6Rα.
Journal ArticleDOI
Integrin cytoplasmic tail interactions.
TL;DR: Key integrin-interacting proteins are reviewed and their roles in regulating integrin activity, localization, and signaling are reviewed.
Journal ArticleDOI
Defining the role of syndecan-4 in mechanotransduction using surface-modification approaches
Robert M. Bellin,James D. Kubicek,Matthew J. Frigault,Andrew J. Kamien,Robert L. Steward,Hillary M. Barnes,Michael B. DiGiacomo,Luke J. Duncan,Christina K. Edgerly,Elizabeth M. Morse,Chan Young Park,Jeffrey J. Fredberg,Chao-Min Cheng,Philip R. LeDuc +13 more
TL;DR: This work demonstrates the existence of a mechanically based initiation molecule, syndecan-4, and finds ERK phosphorylation similar to that shown for mechanotransductive response for integrin-based cell attachments through the use of cytoskeletal disruption agents.